Antitumor strategies based on enhancing--and blocking--effects of interleukin-2.
D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007376:Interleukin-2 / Q000008:administration & dosage* / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2